New telemedicine platform gets financial backing
Russia’s Internet Initiatives Development Fund (IIDF, aka FRII in Russian) has closed a $263,000 investment deal with Qapsula, a new Russian telemedicine service, Firrma.ru reported.
Qapsula has a history of being backed by FRII; it participated in FRII’s ninth acceleration program, and now the government fund will own 25% of the three-year-old start-up.
The start-up is expected to use the money to upgrade the functionality of its service, and put together marketing measures.
The Qapsula telemedicine platform uses its mobile app and chatterbox to remind the user of the next doctor appointment / online consultation and when it may be necessary to go buy a new supply of medicines. To benefit from the service, patients are expected to download the Qapsula app using a QR code indicated on medicine packages. The app enables them to get doctor advice on the pills they are taking, a medical instrument they would like to use, or the clinical course of their diseases. It’s a helper for physicians, too; they get the opportunity to remotely monitor their patients and advise them, if needed. According to Qapsula CEO Dmitry Maznitsa, more than 3,000 physicians representing 85 medical professions have registered on the Qapsula portal, all ready to provide counseling and develop a personalized diagnostics/therapy plan on a 24/7 basis.
Last summer Dmitry Shatalin, the founder and CEO of Medintorg, a Russian medicines importer and supplier, bought 40.8% of Qapsula—reportedly in an effort to make it easier for the start-up to develop lasting relationships with pharmas and medical equipment manufacturers.